Liang Schweizer On Raising $180 Million To Mobilize the Human Immune System To Combat Diseases

Liang Schweizer has now raised close to $180M for her biotech startup. Including a $75M Series D round. Her venture, HiFiBio has acquired funding from top-tier investors like Grand Mount Capital, IDG Capital, Legend Star, and Maison Capital.

In this episode, you will learn:

* Liang Schweizer's top advice for launching a business
* The big vision of HiFiBio
* The future of treatment
* Building a global company culture



Alejandro Cremades · EP 496 Liang Schweizer On Raising $180M To Mobilize the Human Immune System To Combat Diseases
SUBSCRIBE ON:



iTunesGoogle PlayStitcherTuneInRSSSoundCloudSpotify



Go to basecamp.com/dealmakers and sign up today to start a free 30 day trial.